CXCR2 and breast cancer: Inhibited myeloid cell infiltration due to the loss of CXCR2 was also shown to be responsible for suppressed chronic colonic inflammation, colitis-associated tumorigenesis [50] and reduction of metastasis in murine breast cancer tumor model [47].